Published in Gut on June 01, 2004
Retracted Clinical application of contrast enhanced ultrasound to diagnose benign prostatic hyperplasia. Diagn Pathol (2014) 1.39
Diagnosis of pancreatic cancer. HPB (Oxford) (2006) 1.29
Recent developments in diagnosis of pancreatic cancer. BMJ (2004) 1.14
Mass-forming pancreatitis: value of contrast-enhanced ultrasonography. World J Gastroenterol (2006) 1.08
Autoimmune pancreatitis: a review. World J Gastroenterol (2007) 1.06
Diagnosis of pancreatic tumors by endoscopic ultrasonography. World J Radiol (2010) 0.99
Contrast-enhanced harmonic endoscopic ultrasonography of solid pancreatic lesions. Endosc Ultrasound (2013) 0.99
Multimodality imaging of pancreatic ductal adenocarcinoma: a review of the literature. HPB (Oxford) (2012) 0.95
Contrast-enhanced sonography of pancreatic ductal carcinoma using agent detection imaging. J Med Ultrason (2001) (2006) 0.95
Vascular endothelial growth factor receptor type 2-targeted contrast-enhanced US of pancreatic cancer neovasculature in a genetically engineered mouse model: potential for earlier detection. Radiology (2014) 0.95
Quantitative low mechanical index contrast-enhanced endoscopic ultrasound for the differential diagnosis of chronic pseudotumoral pancreatitis and pancreatic cancer. BMC Gastroenterol (2013) 0.93
Improved characterisation of solitary solid pancreatic tumours using contrast enhanced transabdominal ultrasound. J Cancer Res Clin Oncol (2007) 0.93
Contrast-enhanced harmonic endoscopic ultrasound imaging: basic principles, present situation and future perspectives. World J Gastroenterol (2014) 0.91
Small invasive ductal carcinoma of the pancreas distinct from branch duct intraductal papillary mucinous neoplasm. World J Gastroenterol (2009) 0.90
Effectiveness of contrast-enhanced harmonic endoscopic ultrasound for the evaluation of solid pancreatic masses. World J Gastroenterol (2014) 0.89
Contrast-enhanced ultrasonography: advance and current status in abdominal imaging. Ultrasonography (2014) 0.88
Pancreatic carcinoma coexisting with chronic pancreatitis versus tumor-forming pancreatitis: diagnostic utility of the time-signal intensity curve from dynamic contrast-enhanced MR imaging. World J Gastroenterol (2007) 0.88
Comparison of standard-dose and low-dose gemcitabine regimens in pancreatic adenocarcinoma patients: a prospective randomized trial. J Gastroenterol (2006) 0.86
Strategies for early detection of resectable pancreatic cancer. World J Gastroenterol (2014) 0.86
Endosonography in solid and cystic pancreatic tumors. J Interv Gastroenterol (2011) 0.84
Autophagy enhances hepatocellular carcinoma progression by activation of mitochondrial β-oxidation. J Gastroenterol (2013) 0.83
Usefulness of contrast-enhanced ultrasonography in determining treatment efficacy and outcome after pancreatic cancer chemotherapy. World J Gastroenterol (2008) 0.82
Autoimmune pancreatitis: with special reference to a localized variant. J Med Ultrason (2001) (2008) 0.81
Clinical controversies in endoscopic ultrasound. Gastroenterol Rep (Oxf) (2013) 0.81
Diagnostic management of pancreatic cancer. Cancers (Basel) (2011) 0.81
Contrast-enhanced harmonic endoscopic ultrasonography in pancreatic diseases. Diagn Ther Endosc (2012) 0.81
Contrast enhanced ultrasonography in the diagnosis of IgG4-negative autoimmune pancreatitis: A case report. J Interv Gastroenterol (2011) 0.81
Current status and future applications of contrast-enhanced endoscopic ultrasonography. World J Gastrointest Endosc (2014) 0.78
Increased expression of PHD3 represses the HIF-1 signaling pathway and contributes to poor neovascularization in pancreatic ductal adenocarcinoma. J Gastroenterol (2014) 0.76
Evaluation of vascular signal in pancreatic ductal carcinoma using contrast enhanced ultrasonography: effect of systemic chemotherapy. Gut (2005) 0.76
Endoscopic ultrasound advances, part 1: diagnosis. Can J Gastroenterol (2009) 0.76
Interobserver agreement of contrast-enhanced harmonic endoscopic ultrasonography in the evaluation of solid pancreatic lesions. Endosc Int Open (2015) 0.76
Standards of the Polish Ultrasound Society - update. Pancreas examination. J Ultrason (2013) 0.76
The differential diagnosis of chronic pancreatitis. Curr Health Sci J (2009) 0.75
Contrast-enhanced ultrasound of pancreatic tumours. Australas J Ultrasound Med (2015) 0.75
Intra-/Interobserver Agreement of Enhancement Pattern for Pancreatic Head Lesions Using Contrast-Enhanced Ultrasound: According to EFSUMB Guidelines. Diagnostics (Basel) (2012) 0.75
Dynamic contrast-enhanced endoscopic ultrasound: A quantification method. Endosc Ultrasound (2017) 0.75
Imaging techniques used for the real-time assessment of angiogenesis in digestive cancers. World J Gastroenterol (2011) 0.75
Autoimmune pancreatitis: Multimodality non-invasive imaging diagnosis. World J Gastroenterol (2014) 0.75
Clinical significance of vascular assessment by contrast-enhanced harmonic ultrasonography of pancreatic carcinomas. J Gastroenterol (2005) 0.75
Diagnostic value of endoscopic ultrasound-guided directional eFLOW in solid pancreatic lesions. J Med Ultrason (2001) (2013) 0.75
Contrast-enhanced endoscopic ultrasound for differential diagnosis of pancreatic cancer: an updated meta-analysis. Oncotarget (2017) 0.75
Preliminary study of contrast-enhanced harmonic endosonography with second-generation contrast agents. J Med Ultrason (2001) (2008) 0.75
Contrast-enhanced US of ampullary carcinoma: correlations with pathological findings. J Med Ultrason (2001) (2012) 0.75
Differential diagnosis between intraductal papillary mucinous neoplasm with an associated invasive carcinoma and pancreatic ductal adenocarcinoma on ultrasonography: the utility of echo intensity and contrast enhancement. Ultrasonography (2017) 0.75
Pancreatic-phase versus portal vein-phase helical CT of the pancreas: optimal temporal window for evaluation of pancreatic adenocarcinoma. AJR Am J Roentgenol (1999) 1.67
Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT. Radiology (2001) 1.52
Contrast-enhanced subtraction harmonic sonography for evaluating treatment response in patients with hepatocellular carcinoma. AJR Am J Roentgenol (2001) 1.46
Echo-enhanced color- and power-Doppler EUS for the discrimination between focal pancreatitis and pancreatic carcinoma. Gastrointest Endosc (2001) 1.26
Hepatocellular carcinoma: depiction of tumor parenchymal flow with intermittent harmonic power Doppler US during the early arterial phase in dual-display mode. Radiology (2001) 1.24
Differentiation of pancreatic tumours by conventional ultrasound, unenhanced and echo-enhanced power Doppler sonography. Scand J Gastroenterol (2002) 1.24
Percutaneous radiofrequency ablation guided by contrast-enhanced harmonic sonography with artificial pleural effusion for hepatocellular carcinoma in the hepatic dome. AJR Am J Roentgenol (2004) 1.20
Pancreatic cancer: value of dual-phase helical CT in assessing resectability. Radiology (1998) 1.18
Characterization of hepatic tumors: value of contrast-enhanced coded phase-inversion harmonic angio. AJR Am J Roentgenol (2004) 1.17
Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography. AJR Am J Roentgenol (2003) 1.15
Transcatheter arterial chemoembolization of hepatocellular carcinoma: usefulness of coded phase-inversion harmonic sonography. AJR Am J Roentgenol (2003) 1.13
Contrast-enhanced endoscopic ultrasonography with galactose microparticles: SHU508 A (Levovist). Endoscopy (1997) 1.02
Dynamic sonography of pancreatic tumors: comparison with dynamic CT. AJR Am J Roentgenol (2002) 1.01
Inflammatory pancreatic masses: differentiation from ductal carcinomas with contrast-enhanced sonography using carbon dioxide microbubbles. AJR Am J Roentgenol (1997) 0.99
Sonographic diagnosis of pancreatic islet cell tumor: value of intermittent harmonic imaging. J Clin Ultrasound (2001) 0.97
Detection of tumor parenchymal blood flow in hepatic tumors: value of second harmonic imaging with a galactose-based contrast agent. Hepatol Res (2001) 0.91
Assessment of the vascularization of neuroendocrine tumors by stimulated acoustic emission of SH U 508A ultrasound contrast agent and color or power Doppler sonography. Invest Radiol (2000) 0.88
Contrast enhanced color Doppler ultrasonography in diagnosis of pancreatic tumor: two case reports. J Ultrasound Med (1996) 0.85
Ultrasonographic and endoscopic ultrasonographic angiography in pancreatic mass lesions. Acta Radiol (1995) 0.83
A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics (1974) 9.97
[Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. Arerugi (1967) 9.06
A new protein containing an SH2 domain that inhibits JAK kinases. Nature (1997) 6.28
Secretion of cyclolysin, the calmodulin-sensitive adenylate cyclase-haemolysin bifunctional protein of Bordetella pertussis. EMBO J (1988) 4.75
Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver--update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall Med (2012) 4.21
EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis (2005) 4.17
The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J (1999) 3.77
Structural basis for recognition of the tra mRNA precursor by the Sex-lethal protein. Nature (1999) 3.51
Sarin poisoning in Tokyo subway. Lancet (1995) 3.06
High-resolution structure of the oligomerization domain of p53 by multidimensional NMR. Science (1994) 2.98
cDNA sequence of human transforming gene hst and identification of the coding sequence required for transforming activity. Proc Natl Acad Sci U S A (1987) 2.97
Binding of the Drosophila sex-lethal gene product to the alternative splice site of transformer primary transcript. Nature (1990) 2.95
Control of doublesex alternative splicing by transformer and transformer-2 in Drosophila. Science (1991) 2.87
Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology (1992) 2.83
Serum lectin with known structure activates complement through the classical pathway. J Biol Chem (1987) 2.79
Construction of a novel database containing aberrant splicing mutations of mammalian genes. Gene (1994) 2.68
Dynamic changes of the inflammation-based index predict mortality following chemoembolisation for hepatocellular carcinoma: a prospective study. Aliment Pharmacol Ther (2014) 2.66
Pathogenesis of Chiari malformation: a morphometric study of the posterior cranial fossa. J Neurosurg (1997) 2.60
Cloning and characterization of novel CIS family genes. Biochem Biophys Res Commun (1997) 2.51
High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan. Gut (1999) 2.46
Essential role of the small GTPase Rac in disease resistance of rice. Proc Natl Acad Sci U S A (2001) 2.45
Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin. Biochem Biophys Res Commun (1995) 2.42
The three subfamilies of leucine-rich repeat-containing G protein-coupled receptors (LGR): identification of LGR6 and LGR7 and the signaling mechanism for LGR7. Mol Endocrinol (2000) 2.37
Genomic sequence of hst, a transforming gene encoding a protein homologous to fibroblast growth factors and the int-2-encoded protein. Proc Natl Acad Sci U S A (1987) 2.34
Structural and functional characterization of inositol 1,4,5-trisphosphate receptor channel from mouse cerebellum. J Biol Chem (1991) 2.23
Isolation and characterization of an avian hepatic binding protein specific for N-acetylglucosamine-terminated glycoproteins. J Biol Chem (1977) 2.18
The gene for Machado-Joseph disease maps to human chromosome 14q. Nat Genet (1993) 2.18
Sequelae of Kawasaki disease in adolescents and young adults. J Am Coll Cardiol (1996) 2.18
Stiffness of systemic arteries in patients with myocardial infarction. A noninvasive method to predict severity of coronary atherosclerosis. Circulation (1989) 2.14
The molecular basis for the absence of N-glycolylneuraminic acid in humans. J Biol Chem (1998) 2.07
The effect of high-sodium and low-sodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension. Am J Med (1978) 2.05
Preferential excision of the 5' proximal intron from mRNA precursors with two introns as mediated by the cap structure. Proc Natl Acad Sci U S A (1987) 2.04
Isolation and characterization of a mannan-binding protein from rabbit liver. Biochem Biophys Res Commun (1978) 2.04
Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care (1999) 2.01
Airway management of a child with temporomandibular joint ankylosis following otitis media. Anaesthesia (2002) 2.01
Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue. Oncogene (1988) 1.99
K-sam, an amplified gene in stomach cancer, is a member of the heparin-binding growth factor receptor genes. Proc Natl Acad Sci U S A (1990) 1.99
Adult coronary artery disease probably due to childhood Kawasaki disease. Lancet (1992) 1.97
Binding of the Drosophila transformer and transformer-2 proteins to the regulatory elements of doublesex primary transcript for sex-specific RNA processing. Proc Natl Acad Sci U S A (1992) 1.94
Nocturnal blood pressure fall on ambulatory monitoring in a large international database. The "Ad Hoc' Working Group. Hypertension (1997) 1.90
Evidence from multiple gene sequences indicates that termites evolved from wood-feeding cockroaches. Curr Biol (2000) 1.90
New in vitro kinetic model for evaluating bactericidal efficacy of antibiotics. Antimicrob Agents Chemother (1980) 1.89
Cloning of the iron superoxide dismutase gene (sodB) in Escherichia coli K-12. J Bacteriol (1984) 1.86
Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. Pediatrics (2001) 1.85
Isolation and characterization of a mannan-binding protein from human serum. J Biochem (1983) 1.83
Kawasaki disease in families. Pediatrics (1989) 1.83
A secondary structure at the 3' splice site affects the in vitro splicing reaction of mouse immunoglobulin mu chain pre-mRNAs. Nucleic Acids Res (1989) 1.77
Two different RNA binding activities for the AU-rich element and the poly(A) sequence of the mouse neuronal protein mHuC. Nucleic Acids Res (1996) 1.77
Chemical and physical properties of an hepatic membrane protein that specifically binds asialoglycoproteins. J Biol Chem (1976) 1.73
Sli2 (Ypk1), a homologue of mammalian protein kinase SGK, is a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. Mol Cell Biol (2000) 1.72
Transforming gene from human stomach cancers and a noncancerous portion of stomach mucosa. Proc Natl Acad Sci U S A (1986) 1.71
Alteration of the structural properties of starch components by the lack of an isoform of starch branching enzyme in rice seeds. J Biol Chem (1993) 1.71
Gallbladder injuries resulting from blunt abdominal trauma: an experience and review. Ann Surg (1981) 1.71
Stratificational relationship among the main nerves from the dorsal division of the sacral plexus and the innervation of the piriformis. Anat Rec (1992) 1.69
Possible role of Helicobacter pylori infection in early gastric cancer development. Cancer (1994) 1.68
Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients. Clin Cancer Res (1998) 1.66
Effect of the cap structure on pre-mRNA splicing in Xenopus oocyte nuclei. Genes Dev (1989) 1.66
Genetic mapping with a thiamine-requiring auxotroph of Escherichia coli K-12 defective in thiamine phosphate pyrophosphorylase. J Bacteriol (1968) 1.66
Phosphorylation of serine 392 stabilizes the tetramer formation of tumor suppressor protein p53. Biochemistry (1997) 1.66
First interim analysis of the GIDEON (Global Investigation of therapeutic decisions in hepatocellular carcinoma and of its treatment with sorafeNib) non-interventional study. Int J Clin Pract (2012) 1.65
Phenotype and genotype in mucolipidoses II and III alpha/beta: a study of 61 probands. J Med Genet (2009) 1.64
In vitro and in vivo evaluation of ceftezole, a new cephalosporin derivative. Antimicrob Agents Chemother (1976) 1.64
Homeobox protein Hex induces SMemb/nonmuscle myosin heavy chain-B gene expression through the cAMP-responsive element. Circ Res (2001) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Both adenylate cyclase and hemolytic activities are required by Bordetella pertussis to initiate infection. Microb Pathog (1992) 1.60
Relation of enhanced secretion of active matrix metalloproteinases with tumor spread in human hepatocellular carcinoma. Gastroenterology (1997) 1.60
Gene heterogeneity for tetracycline resistance in Staphylococcus spp. Antimicrob Agents Chemother (1990) 1.60
Effects of sarin on the nervous system in rescue team staff members and police officers 3 years after the Tokyo subway sarin attack. Environ Health Perspect (2001) 1.59
Rapid techniques for DNA extraction from routinely processed archival tissue for use in PCR. J Clin Pathol (1994) 1.59
A nationwide incidence survey of Kawasaki disease in 1985-1986 in Japan. J Infect Dis (1988) 1.57
A systematic nerve-sparing radical hysterectomy technique in invasive cervical cancer for preserving postsurgical bladder function. Int J Gynecol Cancer (2005) 1.54
Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT. Radiology (2001) 1.52
Expression of pentraxin 3 (PTX3) in human atherosclerotic lesions. J Pathol (2008) 1.52
Skeletal features and growth patterns in 14 patients with haploinsufficiency of SHOX: implications for the development of Turner syndrome. J Clin Endocrinol Metab (1999) 1.51
Effect of genetic differences in omeprazole metabolism on cure rates for Helicobacter pylori infection and peptic ulcer. Ann Intern Med (1998) 1.51
A serum lectin (mannan-binding protein) has complement-dependent bactericidal activity. J Biochem (1989) 1.50
The nucleotide sequence of cDNA for a Drosophila ribosomal protein with homology to rat ribosomal protein S26. Nucleic Acids Res (1989) 1.48
A craniocervical injury-induced syringomyelia caused by central canal dilation secondary to acquired tonsillar herniation. Case report. J Neurosurg (2001) 1.48
A retroperitoneal bronchogenic cyst with malignant change. Pathol Int (1999) 1.48
Human papillomavirus not found in squamous and large cell lung carcinomas by polymerase chain reaction. Cancer (1994) 1.47
Climbing fiber responses evoked in vestibulocerebellum of rabbit from visual system. J Neurophysiol (1973) 1.47
Role of interleukin-10 on hyporesponsiveness of endotoxin during surgery. Crit Care Med (2000) 1.47
Contrast-enhanced subtraction harmonic sonography for evaluating treatment response in patients with hepatocellular carcinoma. AJR Am J Roentgenol (2001) 1.46
Difference in direct charge-parity violation between charged and neutral B meson decays. Nature (2008) 1.46
Insulin infusion in conscious dogs. Effects on systemic and coronary hemodynamics, regional blood flows, and plasma catecholamines. J Clin Invest (1982) 1.46
Identification, cDNA cloning, and gene expression of soluble starch synthase in rice (Oryza sativa L.) immature seeds. Plant Physiol (1993) 1.43
C1-C2 point monitoring of low-dose cyclosporin a given as a single daily dose in children with steroid-dependent relapsing nephrotic syndrome. Clin Nephrol (2005) 1.43
Mutations in the follicle-stimulating hormone receptor and familial dizygotic twinning. Lancet (2001) 1.43
Dislocated intraocular lens fixation using intraocular cowhitch knot. Am J Ophthalmol (2001) 1.43
An automated prediction of MHC class I-binding peptides based on positional scanning with peptide libraries. Immunogenetics (2000) 1.42
Variable Bcl-2 phenotype in benign and malignant lesions of urothelium. Cancer Lett (1998) 1.42
Lesion mimic mutants of rice with alterations in early signaling events of defense. Plant J (1999) 1.42
Clinical application of the perineal scan: prepartum screening for cord presentation. Am J Obstet Gynecol (1986) 1.42
Four p53 DNA-binding domain peptides bind natural p53-response elements and bend the DNA. Proc Natl Acad Sci U S A (1995) 1.42